pI: 6.7731 |
Length (AA): 591 |
MW (Da): 63986 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 6 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
69 | 378 | 4xbm (B) | 177 | 441 | 37.00 | 0 | 1 | 0.380435 | 2.05 |
165 | 196 | 4bdx (A) | 39 | 79 | 56.00 | 0.17 | 0.95 | 0.420046 | -0.1 |
313 | 343 | 1gps (A) | 14 | 43 | 50.00 | 0.72 | 0.93 | 0.615353 | -1.59 |
429 | 585 | 2gy5 (A) | 211 | 358 | 37.00 | 0 | 1 | 0.532551 | 0.54 |
524 | 567 | 1whe (A) | 36 | 82 | 23.00 | 0.13 | 0.37 | 0.18855 | 0.67 |
533 | 570 | 5ky0 (B) | 454 | 491 | 24.00 | 0.65 | 0.18 | 0.262398 | -0.06 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_128415)
Species | Accession | Gene Product |
---|---|---|
Brugia malayi | Bm1_57400 | EGF-like domain containing protein |
Caenorhabditis elegans | CELE_Y64G10A.7 | Protein Y64G10A.7, isoform B |
Drosophila melanogaster | Dmel_CG2086 | draper |
Echinococcus granulosus | EgrG_000068100 | laminin |
Echinococcus multilocularis | EmuJ_000068100 | laminin |
Homo sapiens | 1953 | multiple EGF-like-domains 6 |
Homo sapiens | ENSG00000145794 | multiple EGF-like-domains 10 |
Homo sapiens | ENSG00000187800 | platelet endothelial aggregation receptor 1 |
Homo sapiens | ENSG00000157890 | multiple EGF-like-domains 11 |
Leishmania braziliensis | LbrM.28.2570 | subtilisin-like serine peptidase,serine peptidase, clan SB, family S8-like protein |
Leishmania donovani | LdBPK_282540.1 | subtilisin-like serine peptidase |
Leishmania infantum | LinJ.28.2540 | subtilisin-like serine peptidase,serine peptidase, clan SB, family S8-like protein |
Leishmania major | LmjF.28.2380 | subtilisin-like serine peptidase,serine peptidase, clan SB, family S8-like protein |
Leishmania mexicana | LmxM.28.2380 | subtilisin-like serine peptidase,serine peptidase, clan SB, family S8-like protein |
Loa Loa (eye worm) | LOAG_07472 | multiple epidermal growth factor-like domains 6 |
Loa Loa (eye worm) | LOAG_06602 | hypothetical protein |
Mus musculus | ENSMUSG00000057751 | multiple EGF-like-domains 6 |
Mus musculus | ENSMUSG00000024593 | multiple EGF-like-domains 10 |
Mus musculus | ENSMUSG00000036466 | multiple EGF-like-domains 11 |
Mus musculus | ENSMUSG00000028073 | platelet endothelial aggregation receptor 1 |
Neospora caninum | NCLIV_001350 | EGF-like domain-containing protein, putative |
Schistosoma japonicum | Sjp_0054220 | Multiple epidermal growth factor-like domains 6 precursor, putative |
Schistosoma japonicum | Sjp_0134560 | Matrilin-2 precursor, putative |
Schistosoma japonicum | Sjp_0100200 | IPR006209,EGF-like;IPR001881,EGF-like calcium-binding;IPR006210,EGF;IPR000152,Aspartic acid and asparagine hydroxylation site;IP |
Schistosoma japonicum | Sjp_0053060 | hypothetical protein |
Schistosoma mansoni | Smp_135210 | egf-like domain protein |
Schmidtea mediterranea | mk4.011108.02 | Pre-mRNA-processing factor 19 homolog |
Schmidtea mediterranea | mk4.017714.00 | |
Schmidtea mediterranea | mk4.000532.12 | Multiple epidermal growth factor like domains protein-1 |
Trichomonas vaginalis | TVAG_485930 | Root-specific lectin precursor, putative |
Trichomonas vaginalis | TVAG_220940 | Metallothionein, putative |
Trichomonas vaginalis | TVAG_182840 | Keratin-associated protein 5-7, putative |
Trichomonas vaginalis | TVAG_486210 | conserved hypothetical protein |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.